“borderline significant”

The results also displayed a borderline significant difference across the genetic risk scores for body fat mass (p = 0.05), percentage of body fat (p = 0.05), serum HDL concentration (p = 0.08), and CRP (p = 0.06).

The IgAN237 score showed a significant correlation with proteinuria (ρ = 0.181, P = 0.011) and a borderline significant correlation with baseline eGFR (ρ = −0.136, P = 0.05) ( Figure 3A ).

A borderline significant interaction (p = 0.05) was observed for one outcome: concordance between stated decision and action taken, where encounters with female clinician/male patient showed increased concordance in the decision aid arm compared to control (8% more concordant encounters).

However, separate analyses pooling data at each quantile found a significant protective association of fructose intakes at the third (9.5%E, RR = 0.95, 95% CI, 0.92–0.98, p = 0.0004) and fourth (11.2%E, RR = 0.93, 95% CI, 0.93–0.98, p = 0.001) quantiles, and a borderline significant protective association at intakes equivalent to the second quantile (7.9%E, RR = 0.97, 95% CI, 0.95–1.00, p = 0.05; Fig. 3 ).

However, there was a borderline significant difference in gender distribution between the clusters ( χ 2 1 =3.84; P =.05).

A borderline significant correlation was present when exciting with 440 nm (r = 0.57, p = 0.05) and 750 nm (r = 0.55, p = 0.06).

PRDX1 protein expression correlated with smaller tumor size ( P = 0.011), low tumor grade ( P = 0.002), negative Ki67 status ( P = 0.004) and lobular subtype ( P = 0.003), whilst there was a borderline significant correlation with positive ER status ( P = 0.05).

Chi-squared analysis revealed a borderline significant difference in the proportion of females medicated (71.4%) compared to males (43.8%) (Χ 2 (1) = 3.92, p = .05).

According to the analysis: Structure: C (2.32) > B (2.21) > A (1.98)— p = .044*, Activity: C (0.91) > A (0.49)— p = .068 (borderline significant), Freedom: C/B (2.13) > A (1.84)— p > .05, Other Factors: No significant difference between groups in Privacy, Emotional Feedback, Support, and Social Interaction ( p > .05).

However, there was a borderline significant sex-difference (P = 0.05) in the association between EPA and AO; and EPA was associated with AO (P = 0.03), SAD (P = 0.03), and WC (P = 0.02) in women, when evaluated in sex-specific analyses using multivariable-adjusted models ( S2 and S3 Tables).

At the day level, exercise was a borderline significant predictor of portion size ( p = .050).

CD63 and SORL1 were significantly modulated in accordance with changes in the microarray assay, and CASP4 was borderline significant (p = 0.05) ( Table 3 ).

The association for obesity became borderline significant ( p = 0.05), with the adjusted odds ratio suggesting potentially lower odds of exercise (AOR = 0.81, 95% CI [0.66, 1.00]); the confidence interval just touching 1.00 indicates this finding is at the threshold of statistical significance.

The association between CRP and thumbnail pain threshold was borderline significant (β = -0.13, P = 0.05).

In this analysis, SDH remained a borderline significant independent predictor of higher GPR values (OR = 1.043, 95% CI: 1.022–1.064; p = 0.05).

As for TMD, the increase was borderline significant ( p = 0.05) in NW group.

Evaluation of systemic markers of inflammation (hs-CRP, IL-6, IL-8 and fibrinogen) only revealed a borderline significant decrease in plasma hs-CRP concentration after doxycycline treatment (−0.51 μg/ml, P =0.050; Table 3 ).

Besides, nontimely initial injections (over than 2 hours) reached a borderline significant (Adjusted OR = 4.14, 95% CI: 1.00–17.18, P = 0.050).

Spearman's rank correlation analysis resulted in borderline significant correlation for IHC versus ISH ( r S : 0.625; p <0.05) and IHC versus microarray ( r S : 0.668; p <0.01), but in significant correlation for ISH versus microarray ( r S : 0.861; p <0.001).

Moreover, in a prospective randomized, double-blind, placebo-controlled trial enrolling 106 patients with both NAFLD and T2DM who were assigned to receive empagliflozin 10 mg ( n = 35), pioglitazone 30 mg ( n = 34), or placebo ( n = 37) for 24 weeks, only a borderline significant decrease in CAP score was observed with empagliflozin compared with placebo (−29.6 dB/m (−39.5 to −19.6) vs. −16.4 dB/m (−25.0 to −7.8), respectively; p = 0.05) [ 39 ].

Of the examined risk factors for UI in adults aged 50 or older, obesity showed a borderline significant relationship, with obese participants reporting a higher UI prevalence (38.3%) than those with a healthy weight (25.0%) and overweight (28.0%) ( P = 0.05) [ Table 4 ].

Coronary artery disease was borderline significant as a determinant of renal dysfunction (OR 1.35, 95% CI 1.00 to 1.82, p = 0.05) (Table 2 ).

Longer episode duration was associated with a small borderline significant reduction in treatment effectiveness (β = 0.24, p = 0.05), irrespective of treatment protocol (episode duration × Treatment: β = −0.23, p = 0.31); no difference was observed between patients with MDD vs.

A borderline significant (Rho=0.26; p=0.05) association was observed between the arterial and muscular expression of CDKN2A/p16 INK4a ( Suppl.

But the difference in the mean changes of social performance was borderline significant (7.16 ± 13.59 vs –0.96 ± 12.01, p = 0.05).